Amir Dagan Named CEO of Hadassah Medical Organization’s Technology Transfer Company
Dagan brings 20 years’ experience to Hadasit, which commercializes research done at Hadassah’s hospitals. Hadasit’s portfolio of more than 250 active patent families in therapeutics, diagnostics and medical devices generates average annual revenues of $13 million.